Polskie Towarzystwo Badania Bólu

Polish Association for the Study of Pain

Polskie Towarzystwo Badania Bólu

Polish Association for the Study of Pain



Co robimy

Organizujemy zjazdy, sympozja, konferencje i spotkania naukowe
Prowadzimy specjalistyczne szkolenia lekarzy w zakresie leczenia bólu
Współpracujemy z pokrewnymi naukowymi towarzystwami krajowymi i zagranicznymi.
Poradniom stosującym uznane standardy leczenia bólu nadajemy Certyfikaty PTBB
Współfinansujemy udział członków w konferencjach z zakresu medycyny bólu.
Od roku 2000 wydajemy naukowy kwartalnik Ból oraz biuletyny informacyjne

Rozpocznij studia podyplomowe - Medycyna bez bólu
logo Global Year 2021
logo kwartalnik BÓL
Partner Towarzystwa: Szpital bez bólu
logo fundacja medycyny bolu 240
 Nie Ból Się


logo efic 240
logo ESREA 240
logo sip 240



Press Release


  • Creating further awareness for pain and its treatment
  • Support young scientists to bring out best pain relief for patients

Aachen/Brussels, 23 June 2016. For the tenth time, young European scientists who have an innovative pain research idea, are called upon to apply for one of the most prestigious and highly regarded pain research grants worldwide: The EFIC-GRÜNENTHAL Grant (E-G-G).

The long lasting collaboration between the European Pain Federation EFIC® and the German pain expert Grünenthal has one common goal: Create awareness for pain management and support those who are able to bring out individual treatments for pain patients. “Our intensive and fruitful cooperation unconditionally pursues the target to bring the best pain relief to every individual patient”, highlights Dr Luis Villanueva, Chair of the EFIC® Committee on Scientific Research. He continues:“As pain still poses a huge economic and social burden, we know about the importance to consider and improve our joint working to find successful ways to apply best pain treatment in the future”.

The biennial grant sponsored by Grünenthal totalling €200,000 enables young scientists to translate their innovative pain research idea into practise, at a crucial time in their career when it is often extremly difficult for them to receive research funds. Individual grants are valued at up to € 40,000 per project for a duration of up to two years. The decision on award winners is made independently by the EFIC® Committee on Scientific Research.

“Now announced for the 10th time since the first call in 2004, the continuous rising number of EFIC-GRÜNENTHAL Grant applications shows that the E-G-G is a major way to promote pain research”, emphasizes Dr Frank Laschewski, Head of Medical Affairs Europe and North America of the Grünenthal Group. “Since diagnosis and management of pain can be very complex, many patients still do not receive adequate treatment. Therefore, it is Grünenthal’s longterm commitment to drive research in this field.” Today well established, the grant receives growing awareness in the community of distinguished pain experts, and moreover, winners become part of an international network in the field. Learn more about this research grant on the EFIC-GRÜNENTHAL Grant YouTube Channel.

Interested young pain researchers who meet the criteria for application, can apply online by end of this year at

About the European Pain Federation EFIC®

With headquarters in Diegem/Brussels, the European Pain Federation EFIC® is a multidisciplinary professional organisation in the field of pain research and medicine,

consisting of the 37 chapters of the International Association for the Study of Pain (IASP®), which are the IASP approved official National Pain Societies in each country. Established in 1993, EFIC’s constituent chapters represent Pain Societies from 37 European countries and more than 20,000 physicians, basic researchers, nurses, physiotherapists, psychologists and other healthcare professionals across Europe, who are involved in pain management and pain research. For more information, please visit

About Grünenthal

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,300 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information:


Grünenthal Group
Steffen Fritzsche
Head Corporate Communications
Phone: +49 241 569-1335
Email: Ten adres pocztowy jest chroniony przed spamowaniem. Aby go zobaczyć, konieczne jest włączenie w przeglądarce obsługi JavaScript.

European Pain Federation EFIC®
Christel Geevels
Phone: +32 2 251 55 10
Fax: +32 2 251 48 10
Email: Ten adres pocztowy jest chroniony przed spamowaniem. Aby go zobaczyć, konieczne jest włączenie w przeglądarce obsługi JavaScript.

Media Contact:
Project management by Annika Walterscheid
Annika Walterscheid
Phone: +49 174 8806313
Email: Ten adres pocztowy jest chroniony przed spamowaniem. Aby go zobaczyć, konieczne jest włączenie w przeglądarce obsługi JavaScript.

Current press materials are available on request.